hackint0sh/temp-data huggingface dataset:
protocolSection identificationModule nctId: NCT06308536, orgStudyIdInfo id: KY-2023-045, briefTitle: Application of Concentrated Growth Factors in Alveolar Ridge Preservation, statusModule overallStatus: RECRUITING, startDateStruct date: 2023-05-09, primaryCompletionDateStruct date: 2024-10-01, completionDateStruct date: 2025-04-01, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: The Fourth Affiliated Hospital of Zhejiang University School of Medicine, class: OTHER, descriptionModule briefSummary: To explore the role of CGF in the regeneration or preservation of soft and hard tissues during tooth extraction site preservation surgery., conditionsModule conditions: Alveolar Ridge Preservation, conditions: Concentrated Growth Factor, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: SINGLE, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 20, type: ESTIMATED, armsInterventionsModule interventions name: bone powder + collagen membrane, interventions name: bone powder + collagen membrane + CGF membrane, interventions name: bone powder mixed wih CGF gel + collagen membrane + CGF membrane, interventions name: bone powder + CGF membrane, outcomesModule primaryOutcomes measure: the width of keratinized gingiva, primaryOutcomes measure: the horizontal width (from buccal to lingual at the alveolar top ) of gingiva, primaryOutcomes measure: the horizontal bone resorption of alveolar crest, primaryOutcomes measure: the vertical bone resorption of alveolar crest, primaryOutcomes measure: the average gray value of alveolar bone, secondaryOutcomes measure: Landry wound healing index, secondaryOutcomes measure: reduction in membrane exposure area, secondaryOutcomes measure: pain score, eligibilityModule sex: ALL, minimumAge: 25 Years, maximumAge: 45 Years, stdAges: ADULT, contactsLocationsModule locations facility: The Fourth Affiliated Hospital Zhejiang University School of Medicine, status: RECRUITING, city: Yiwu, state: Zhejiang Procince, zip: 310000, country: China, contacts name: Genying Zhuang, Master, role: CONTACT, phone: 13758195143, email: 20918620@zju.edu.cn, geoPoint lat: 29.31506, lon: 120.07676, hasResults: False
protocolSection identificationModule nctId: NCT06308523, orgStudyIdInfo id: AP303-PK-02, briefTitle: A Study to Evaluate the Safety, Tolerability, PK and PD of AP303 in Healthy Chinese Participants, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-03-30, primaryCompletionDateStruct date: 2024-06-10, completionDateStruct date: 2024-06-30, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Alebund Pharmaceuticals, class: INDUSTRY, descriptionModule briefSummary: The study will be a single center, double-blind, randomized, placebo-controlled, multiple-ascending-dose study to evaluate the safety, tolerability, PK and PD of AP303 following 2-week oral administration to healthy Chinese participants., conditionsModule conditions: Healthy Subjects, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: RANDOMIZED, interventionModel: SEQUENTIAL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 18, type: ESTIMATED, armsInterventionsModule interventions name: AP303 150 μg, interventions name: Placebo 150 μg, interventions name: AP303 300 μg, interventions name: Placebo 300 μg, outcomesModule primaryOutcomes measure: Cmax, primaryOutcomes measure: Tmax, primaryOutcomes measure: AUC0-24h, primaryOutcomes measure: AUC0-last, primaryOutcomes measure: AUC0-inf, primaryOutcomes measure: AUC0-t, primaryOutcomes measure: t1/2, primaryOutcomes measure: CL/F, primaryOutcomes measure: V/F, primaryOutcomes measure: Cav, primaryOutcomes measure: Ctrough, primaryOutcomes measure: Rac, primaryOutcomes measure: Incidence and severity of adverse events, primaryOutcomes measure: Incidence of laboratory abnormalities, based on hematology, clinical chemistry, coagulation and urinalysis test results, primaryOutcomes measure: Effect of AP303 on ECG parameters, primaryOutcomes measure: Effect of AP303 on ECG parameters, primaryOutcomes measure: Effect of AP303 on ECG parameters, primaryOutcomes measure: Effect of AP303 on ECG parameters, primaryOutcomes measure: Effect of AP303 on ECG parameters, primaryOutcomes measure: Effect of AP303 on ECG parameters, primaryOutcomes measure: Vital signs, primaryOutcomes measure: Effect of AP303 on physical examination result, primaryOutcomes measure: body weight, secondaryOutcomes measure: Fasting glucose, secondaryOutcomes measure: Fasting lipid profile, secondaryOutcomes measure: Serum creatinine, secondaryOutcomes measure: eGFR, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 50 Years, stdAges: ADULT, contactsLocationsModule, hasResults: False
protocolSection identificationModule nctId: NCT06308510, orgStudyIdInfo id: MEC-2024tba, briefTitle: Detection of Aneuploidy in Cell Free DNA to Improve the Sensitivity of Diagnostic Peritoneal Lavage in Gastric Cancer, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07, primaryCompletionDateStruct date: 2026-07, completionDateStruct date: 2028-07, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Erasmus Medical Center, class: OTHER, descriptionModule briefSummary: Aneuploidy may be used as a more sensitive diagnostic tool to detect peritoneal metastasis compared to conventional cytology and imaging techniques. Our aim is to establish whether aneuploidy as detected in cfDNA (as a measure for ctDNA) in PLF of patients with GC may hold value as an additional staging and tumor evaluation method in GC patients., conditionsModule conditions: Gastric Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 63, type: ESTIMATED, armsInterventionsModule interventions name: collection additional peritoneal lavage fluid, outcomesModule primaryOutcomes measure: Sensitivity mFast-SeqS, secondaryOutcomes measure: DFS, secondaryOutcomes measure: Concordance detection rates peritoneal dissemination, eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Erasmus MC, city: Rotterdam, zip: 3015GD, country: Netherlands, contacts name: Jessie Huizer, Drs, role: CONTACT, phone: +31107034523, email: t.j.huizer@erasmusmc.nl, contacts name: Niels Guchelaar, role: CONTACT, email: n.guchelaar@erasmusmc.nl, geoPoint lat: 51.9225, lon: 4.47917, hasResults: False
protocolSection identificationModule nctId: NCT06308497, orgStudyIdInfo id: 2024-Q10PREGNANT, briefTitle: Adjunctive Periodontal Treatment With Coenzyme Q10 in Association With Probiotics for Pregnant Women, statusModule overallStatus: ENROLLING_BY_INVITATION, startDateStruct date: 2024-03-10, primaryCompletionDateStruct date: 2024-10-15, completionDateStruct date: 2024-10-20, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-04-26, sponsorCollaboratorsModule leadSponsor name: University of Pavia, class: OTHER, descriptionModule briefSummary: The aim of the study is to assess if probiotic supplementation can be effective in reducing periodontal clinical parameters in a 6-month study on pregnant patients., conditionsModule conditions: Periodontal Diseases, conditions: Pregnancy Related, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Double-arm parallel design, primaryPurpose: TREATMENT, maskingInfo masking: TRIPLE, maskingDescription: Products will be concealed., whoMasked: PARTICIPANT, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 40, type: ESTIMATED, armsInterventionsModule interventions name: Probiotic Treatment, interventions name: Standard Treatment, outcomesModule primaryOutcomes measure: Change in Plaque Index, primaryOutcomes measure: Change in Recession (R), primaryOutcomes measure: Change in Clinical Attachment Loss (CAL), primaryOutcomes measure: Change in Bleeding on Probing (BoP), primaryOutcomes measure: Change in Probing Pocket Depth (PPD), primaryOutcomes measure: Change in API - Approximal Plaque Index, primaryOutcomes measure: Change in Plaque Control Record (PCR%), primaryOutcomes measure: Change in Papillary Marginal Gingival Index (PMGI), primaryOutcomes measure: Change in modified Marginal Gingival Index (mMGI), eligibilityModule sex: FEMALE, minimumAge: 18 Years, maximumAge: 40 Years, stdAges: ADULT, contactsLocationsModule locations facility: Unit of Dental Hygiene - Section of Dentistry - Department of Clinical, Surgical, Diagnostic and Paediatrics - University of Pavia, city: Pavia, state: Lombardy, zip: 27100, country: Italy, geoPoint lat: 45.19205, lon: 9.15917, hasResults: False
protocolSection identificationModule nctId: NCT06308484, orgStudyIdInfo id: TRR265 C02 FP2, briefTitle: Neuromodulation and Mindfulness Patients With AUD, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03-20, primaryCompletionDateStruct date: 2027-06-30, completionDateStruct date: 2027-06-30, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Charite University, Berlin, Germany, class: OTHER, collaborators name: Medical School Berlin, descriptionModule briefSummary: Our primary objective is to integrate tVNS and mindfulness meditation within a structured mindfulness-based relapse prevention (MBRP) program for detoxified alcohol-dependent patients (AD). We aim to determine whether neuromodulation can enhance mindfulness-based relapse prevention compared to mindfulness practice alone. In this context, we will investigate potential changes in the interaction of top-down control and cue reactivity, as well as assess the severity of AUD. Measurements of drinking behavior, cravings, and abstinence rates will be conducted up to three months post-treatment. Our second objective is to examine the causal role of frontal midline theta oscillations (FMΘ) in MBRP and cognitive control. To achieve this, we will first establish closed-loop amplitude-modulated transcranial alternating current stimulation (CLAM-tACS) to selectively modulate FMΘ oscillations during MBRP meditation exercises in AUD patients (2)., conditionsModule conditions: Alcohol Dependence, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: BASIC_SCIENCE, maskingInfo masking: SINGLE, whoMasked: PARTICIPANT, enrollmentInfo count: 140, type: ESTIMATED, armsInterventionsModule interventions name: Transcutaneous vagus nerve stimulation, interventions name: Closed-loop AM-tACS, outcomesModule primaryOutcomes measure: Cognitive Control, primaryOutcomes measure: Interoception, primaryOutcomes measure: Cue-Reactivity, secondaryOutcomes measure: Heartrate, secondaryOutcomes measure: Heartrate Variability, secondaryOutcomes measure: Mindfulness, secondaryOutcomes measure: Alcohol consumption, secondaryOutcomes measure: Dependence Severity (Alcohol Dependence Scale), eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 70 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Charité - Berlin University of Medicine, status: RECRUITING, city: Berlin, zip: 10117, country: Germany, contacts name: Rosenthal, role: CONTACT, phone: 0049 30 450 517040, geoPoint lat: 52.52437, lon: 13.41053, hasResults: False
protocolSection identificationModule nctId: NCT06308471, orgStudyIdInfo id: ege üniversitesi, briefTitle: Effect of Baby Massage on Oral Motor Skills of Premature Babies, statusModule overallStatus: COMPLETED, startDateStruct date: 2021-09-01, primaryCompletionDateStruct date: 2023-05-01, completionDateStruct date: 2023-05-01, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Ege University, class: OTHER, descriptionModule briefSummary: This experimental research was conducted in a single-blind, block randomized controlled design type.The primary purpose of the study is to examine the effect of premature baby massage on oral motor coordination skills. The secondary aim is to evaluate the consistency of use of The Oral Feeding clinical scale in premature babies in Turkey.As a result of the power analysis, baby massage was applied to the intervention group (n = 20) and oral stimulation with the Fucile protocol was applied to the control group (n = 20).Comparative results were evaluated statistically., conditionsModule conditions: Infant, Premature, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Baby massage was applied to the intervention group (20) of the study, and oral stimulation was applied with the Fucile protocol to the control group (20)., primaryPurpose: SUPPORTIVE_CARE, maskingInfo masking: DOUBLE, maskingDescription: Professional nurses who evaluate nutrition do not know which group they belong to in the study.They do not know which group the premature babies are in due to their age., whoMasked: PARTICIPANT, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 40, type: ACTUAL, armsInterventionsModule interventions name: Baby massage was applied to the intervention group (n=20) of the study, interventions name: Oral stimulation, outcomesModule primaryOutcomes measure: time for first oral feeding, primaryOutcomes measure: time for full oral feeding, secondaryOutcomes measure: discharge time, eligibilityModule sex: ALL, minimumAge: 1 Day, maximumAge: 28 Days, stdAges: CHILD, contactsLocationsModule locations facility: Ege University, city: Izmir, state: Bornova, zip: 35040, country: Turkey, geoPoint lat: 38.41273, lon: 27.13838, hasResults: False
protocolSection identificationModule nctId: NCT06308458, orgStudyIdInfo id: P.T.REC/012/003966, briefTitle: Breather Exerciser Trainer on Diaphragmatic Mobility And Thickness, statusModule overallStatus: COMPLETED, startDateStruct date: 2023-03-30, primaryCompletionDateStruct date: 2024-01-01, completionDateStruct date: 2024-03-01, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Adly A Adam, class: OTHER, descriptionModule briefSummary: The purpose of this study is to the effect of the breather exerciser trainer on diaphragmatic mobility and thickness in elderly., conditionsModule conditions: Aging Well, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, interventionModelDescription: Prospective pre/ posttreatment, randomized controlled study, primaryPurpose: TREATMENT, maskingInfo masking: DOUBLE, maskingDescription: Double masking (Investigator, Outcomes assessor, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 60, type: ACTUAL, armsInterventionsModule interventions name: Breather Exerciser Trainer, interventions name: Conventional Breathing Exercise, outcomesModule primaryOutcomes measure: Diaphragmatic thickness in millimeters, primaryOutcomes measure: Diaphragmatic mobility in centimeters, secondaryOutcomes measure: Functional Capacity, secondaryOutcomes measure: Geriatric Quality of life Questionnaire, secondaryOutcomes measure: Geriatric Quality of Life, eligibilityModule sex: ALL, minimumAge: 65 Years, maximumAge: 75 Years, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Faculty of Physical Therapy, city: Giza, country: Egypt, geoPoint lat: 30.00808, lon: 31.21093, hasResults: False
protocolSection identificationModule nctId: NCT06308432, orgStudyIdInfo id: UCAMCFE-00036, briefTitle: Sweat Rate Measurement With a Sensor (Wearable) in Different Climatic Conditions With Road Cyclists., acronym: CYSU, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-02-19, primaryCompletionDateStruct date: 2024-04-12, completionDateStruct date: 2024-05-20, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Universidad Católica San Antonio de Murcia, class: OTHER, descriptionModule briefSummary: Controlled, double-blind, crossover clinical trial with six parallel arms depending on the combination of temperature and humidity (22º and 40% humidity, 35º 40% humidity and 35º and 65% humidity), with two differents intensity, to investigate and validate the physiological use of a sensor in recreational road cyclists., conditionsModule conditions: Sweat, designModule studyType: INTERVENTIONAL, phases: NA, designInfo allocation: RANDOMIZED, interventionModel: CROSSOVER, primaryPurpose: OTHER, maskingInfo masking: SINGLE, whoMasked: INVESTIGATOR, enrollmentInfo count: 12, type: ESTIMATED, armsInterventionsModule interventions name: Low intensity, interventions name: Low temperature, interventions name: Low Humidity, interventions name: High intensity, interventions name: High temperature, interventions name: High humidity, outcomesModule primaryOutcomes measure: Sweat, secondaryOutcomes measure: Microcapillary Blood, secondaryOutcomes measure: Heart Rate, secondaryOutcomes measure: Fatigue, secondaryOutcomes measure: Temperature on the forehead, secondaryOutcomes measure: Temperature in the ear, secondaryOutcomes measure: Sleep efficiency, secondaryOutcomes measure: Karolinska drowsiness scale, eligibilityModule sex: MALE, minimumAge: 18 Years, maximumAge: 45 Years, stdAges: ADULT, contactsLocationsModule locations facility: Catholic University of Murcia, status: RECRUITING, city: Murcia, zip: 30107, country: Spain, contacts name: Fco Javier López Román, role: CONTACT, phone: 968278523, email: jlroman@ucam.edu, geoPoint lat: 37.98704, lon: -1.13004, hasResults: False
protocolSection identificationModule nctId: NCT06308419, orgStudyIdInfo id: 2023-0900, secondaryIdInfos id: NCI-2024-01751, type: OTHER, domain: NCI-CTRP Clinical Registry, briefTitle: A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions, statusModule overallStatus: NOT_YET_RECRUITING, startDateStruct date: 2024-07-31, primaryCompletionDateStruct date: 2029-02-01, completionDateStruct date: 2031-02-01, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-15, sponsorCollaboratorsModule leadSponsor name: M.D. Anderson Cancer Center, class: OTHER, collaborators name: Aadi Bioscience, descriptionModule briefSummary: To find a recommended dose of gemcitabine and nab-sirolimus that can be given in combination to participants with advanced leiomyosarcomas or soft-tissue sarcomas., conditionsModule conditions: Leiomyosarcoma, conditions: Soft-tissue Sarcomas, designModule studyType: INTERVENTIONAL, phases: PHASE1, designInfo allocation: NA, interventionModel: SINGLE_GROUP, primaryPurpose: TREATMENT, maskingInfo masking: NONE, enrollmentInfo count: 12, type: ESTIMATED, armsInterventionsModule interventions name: Gemcitabine, interventions name: Nab-Sirolimus, outcomesModule primaryOutcomes measure: Safety and adverse events (AEs), eligibilityModule sex: ALL, minimumAge: 18 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: MD Anderson Cancer Center, city: Houston, state: Texas, zip: 77030, country: United States, contacts name: Elise Nassif, MD, role: CONTACT, phone: 281-460-0607, email: efnassif@mdanderson.org, contacts name: Gracy Zacharian, BSN,MSN,RN, role: CONTACT, phone: (713) 792-2669, email: gzachari@mdanderson.org, contacts name: Elise Nassif, MD, role: PRINCIPAL_INVESTIGATOR, geoPoint lat: 29.76328, lon: -95.36327, hasResults: False
protocolSection identificationModule nctId: NCT06308367, orgStudyIdInfo id: XWTEBS, briefTitle: The Therapeutic Effect of Betaine in Syringomyelia, statusModule overallStatus: RECRUITING, startDateStruct date: 2024-03, primaryCompletionDateStruct date: 2027-03, completionDateStruct date: 2028-03, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Xuanwu Hospital, Beijing, class: OTHER, descriptionModule briefSummary: Purpose: This clinical trial aims to evaluate the indications, therapeutic effects and side effects of betaine in refractory syringomyelia.Primary outcome measure: The primary endpoint is the change of ASIA at week 12. The clinical efficacy is defined as ASIA increase ≥ 1 at week 12, as compared with that before betaine usage., conditionsModule conditions: Syringomyelia, designModule studyType: INTERVENTIONAL, phases: PHASE2, designInfo allocation: RANDOMIZED, interventionModel: PARALLEL, primaryPurpose: TREATMENT, maskingInfo masking: QUADRUPLE, whoMasked: PARTICIPANT, whoMasked: CARE_PROVIDER, whoMasked: INVESTIGATOR, whoMasked: OUTCOMES_ASSESSOR, enrollmentInfo count: 30, type: ESTIMATED, armsInterventionsModule interventions name: Betaine, interventions name: Placebo, outcomesModule primaryOutcomes measure: ASIA Score, secondaryOutcomes measure: syringomyelia remission, secondaryOutcomes measure: Electrophysiology results, secondaryOutcomes measure: Visual Analog Scale (VAS), secondaryOutcomes measure: Klekamp and Sammi syringomyelia scale, secondaryOutcomes measure: modified Japanese Orthopaedic Association Scores (mJOA), secondaryOutcomes measure: xuanwu syringomyelia scale, secondaryOutcomes measure: Incidence of complications, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 80 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fengzeng Jian, status: RECRUITING, city: Beijing, state: Beijing, zip: 100053, country: China, contacts name: Yuan Chenghua, role: CONTACT, email: yuanchenghua@ccmu.edu.cn, contacts name: Jian Fengzeng, role: CONTACT, email: jianfengzeng@xwh.ccmu.edu.cn, contacts name: jian guan, dr, role: SUB_INVESTIGATOR, geoPoint lat: 39.9075, lon: 116.39723, hasResults: False
protocolSection identificationModule nctId: NCT06308354, orgStudyIdInfo id: CRC dataset, briefTitle: Colorectal Cancer Dataset in Xijing Hospital From 2011, statusModule overallStatus: RECRUITING, startDateStruct date: 2011-01-01, primaryCompletionDateStruct date: 2048-01-01, completionDateStruct date: 2048-01-01, studyFirstPostDateStruct date: 2024-03-13, lastUpdatePostDateStruct date: 2024-03-13, sponsorCollaboratorsModule leadSponsor name: Xijing Hospital, class: OTHER, descriptionModule briefSummary: To compare the differences of clinical pathological, treatment and prognosis in the guided subgroups in colorectal cancer, the investigator enrolled all the colorectal cancer patients who underwent surgery and were hospitalized in the Xijing hospital., conditionsModule conditions: Prognostic Cancer Model, conditions: Chemotherapy, conditions: Nutrition Related Cancer, designModule studyType: OBSERVATIONAL, designInfo observationalModel: COHORT, timePerspective: PROSPECTIVE, enrollmentInfo count: 40000, type: ESTIMATED, armsInterventionsModule, outcomesModule primaryOutcomes measure: overall survival, primaryOutcomes measure: DFS, eligibilityModule sex: ALL, minimumAge: 18 Years, maximumAge: 100 Years, stdAges: ADULT, stdAges: OLDER_ADULT, contactsLocationsModule locations facility: Fourth Military Medical University, status: RECRUITING, city: Xi'an, state: Shaanxi, country: China, contacts name: Jipeng Li, role: CONTACT, phone: +86-029-84771533, geoPoint lat: 34.25833, lon: 108.92861, hasResults: False